Literature DB >> 12465052

Parkinson's disease and dementia with Lewy bodies: one disease or two?

Irene Hegeman Richard1, Michelle Papka, Ana Rubio, Roger Kurlan.   

Abstract

Parkinson's disease (PD) and dementia with Lewy bodies (DLB) have clinical features in common and are both characterized neuropathologically by the presence of Lewy bodies (LBs). We conducted a clinicopathological correlation pilot study to better understand whether PD and DLB represent two distinct nosological entities or rather exist along the spectrum of a single LB disease. A neuropathologist blinded to clinical diagnoses evaluated brains with largely pure LB pathology to determine LB distribution and frequency. Research clinicians blinded to LB distribution and frequency determined consensus clinical diagnoses. Clinical features separated cases into two groups, one having features most compatible with PD and the other with DLB. The groups were distinguishable mainly by the time course of clinical symptoms. Although the presence of neocortical LBs was more common in the group of patients with clinical features of DLB, neocortical LBs were also present in 1 member of the PD group and even in the clinically normal control subject. Thus, there appear to be two clinical syndromes, distinguished mainly by the time course of symptoms. The mechanisms responsible for the different clinical presentations are not known, and the issue of whether PD and DLB represent two distinct diseases remains unsettled. Copyright 2002 Movement Disorder Society

Entities:  

Mesh:

Year:  2002        PMID: 12465052     DOI: 10.1002/mds.10274

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  15 in total

1.  Neuroprotective upregulation of endogenous α-synuclein precedes ubiquitination in cultured dopaminergic neurons.

Authors:  R E J Musgrove; A E King; T C Dickson
Journal:  Neurotox Res       Date:  2010-07-09       Impact factor: 3.911

Review 2.  Psychotic symptoms in Parkinson's disease. From description to etiology.

Authors:  Spiridon Papapetropoulos; D C Mash
Journal:  J Neurol       Date:  2005-07       Impact factor: 4.849

3.  Parkinson disease and incidental Lewy body disease: Just a question of time?

Authors:  Diego Iacono; Maria Geraci-Erck; Marcie L Rabin; Charles H Adler; Geidy Serrano; Thomas G Beach; Roger Kurlan
Journal:  Neurology       Date:  2015-10-14       Impact factor: 9.910

Review 4.  Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2017-12-08       Impact factor: 3.575

5.  Factors associated with drug-induced visual hallucinations in Parkinson's disease.

Authors:  Spiridon Papapetropoulos; Andreas A Argyriou; John Ellul
Journal:  J Neurol       Date:  2005-04-18       Impact factor: 4.849

Review 6.  Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies.

Authors:  David J Irwin; Virginia M-Y Lee; John Q Trojanowski
Journal:  Nat Rev Neurosci       Date:  2013-07-31       Impact factor: 34.870

Review 7.  Dementia in idiopathic Parkinson's syndrome.

Authors:  Gerd A Fuchs; Irene Gemende; Birgit Herting; Mathias R Lemke; Christian Oehlwein; Heinz Reichmann; Jürgen Rieke; David Emmans; Jens Volkmann
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849

Review 8.  Familial occurrence of dementia with Lewy bodies.

Authors:  Debby W Tsuang; Lillian DiGiacomo; Thomas D Bird
Journal:  Am J Geriatr Psychiatry       Date:  2004 Mar-Apr       Impact factor: 4.105

9.  Lewy body cortical involvement may not always predict dementia in Parkinson's disease.

Authors:  C Colosimo; A J Hughes; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-07       Impact factor: 10.154

10.  Cerebral amyloid angiopathy in Lewy body disease.

Authors:  K A Jellinger; J Attems
Journal:  J Neural Transm (Vienna)       Date:  2008-02-26       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.